nonprofit logo

Aids Vaccine Advocacy Coalition

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 943240841 ✦ New york, NY ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Aids Vaccine Advocacy Coalition?

The Aids Vaccine Advocacy Coalition is a nonprofit organization based in New York, dedicated to expanding access to HIV/AIDS prevention. Their Product Introduction Program identifies and addresses needs and gaps in three priority countries, developing adaptable and scalable tools to support other countries. The coalition collaborates with various funders, product developers, and organizations, including the Bill and Melinda Gates Foundation, to create a mechanism that aids product developers, funders, and country programs in identifying and removing barriers to improved products and accelerated introduction. Their mission is to accelerate the ethical development of effective HIV prevention options and ensure access to these options for everyone in need, contributing to a comprehensive integrated path to global health equity. The organization has a workforce of 36 employees.


Official website here: www.avac.org

What are the reviews and ratings of this charity?

Charity Navigator Rating: 99% - Four-Star out of Four Stars

The Aids Vaccine Advocacy Coalition has achieved an impressive 99% rating on Charity Navigator, reflecting strong performance in several key areas. The rating indicates robust accountability and financial practices, with a perfect score in board independence and the absence of material asset diversion. The organization demonstrates transparency through well-documented policies and proactive financial oversight, ensuring that donor funds are managed effectively.

In terms of program expenses, the coalition allocates 86.91% of its budget towards its mission, highlighting a commitment to impactful initiatives. The fundraising efficiency is exemplary, marked by a $0.00 cost, indicating that the organization raises funds without incurring significant expenses. Additionally, the working capital ratio is sound, suggesting that the organization has sufficient resources to meet its short-term obligations.

However, it's worth noting that the scoring in leadership and adaptability, while perfect, relies on evidence that showcases the organization's responses to external changes, such as the challenges posed by COVID-19. Overall, the Aids Vaccine Advocacy Coalition is recognized as a well-managed and effective nonprofit, making strides in the fight against AIDS through advocacy and education.


This AI summary has been generated from information found on Charity Navigator.

Is Aids Vaccine Advocacy Coalition legitimate?

Aids Vaccine Advocacy Coalition is a legitimate nonprofit organization registered as a 501(c)(3) entity. Aids Vaccine Advocacy Coalition submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $1,004,275
Professional Fundraising Fees: $0
Other Salaries and Wages: $3,660,773

For more financial information, click here


Official website here: www.avac.org

What is the mission statement of Aids Vaccine Advocacy Coalition?

The Aids Vaccine Advocacy Coalition works towards accelerating the ethical development of effective HIV prevention options and ensuring access to these solutions for those in need, contributing to a comprehensive integrated path to global health equity. Their Product Introduction Program aims to identify and address needs and gaps, providing targeted tools, support, and platforms to expand access to HIV/AIDS prevention. The program focuses on successful scale-up and introduction in priority countries, developing adaptable and scalable tools for other countries, supporting the development of marketable products, and creating a flexible mechanism to assist product developers, funders, and country programs in overcoming barriers to improved products and accelerated introduction. The Coalition collaborates with various partners, including the Bill and Melinda Gates Foundation, Children's Investment Fund Foundation, World Health Organization, Population Council, Viatris, Mann Global Health, Medicines360, USAID, Catalyst Global, HIV Prevention Trials Network, and Clinton Health Access Initiative.


Official website here: www.avac.org

Who is the CEO of Aids Vaccine Advocacy Coalition?

Mitchell Warren is the Executive Director of Aids Vaccine Advocacy Coalition.


Official website here: www.avac.org

What is the revenue of Aids Vaccine Advocacy Coalition?

Aids Vaccine Advocacy Coalition's revenue in 2022 was $14,790,975.


Official website here: www.avac.org

Who are the executives of Aids Vaccine Advocacy Coalition and what are their salaries?

The average compensation at Aids Vaccine Advocacy Coalition during 2022 was $129,585. There are 36 employees at Aids Vaccine Advocacy Coalition.


Here are 24 key members and their salaries:


Mitchell Warren (Executive Director)
  • Compensation: $380,391
  • Related: $0
  • Other: $63,403
Alexandre Menezes (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Anne-Marie Duliege (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Blair Hanewall (President)
  • Compensation: $0
  • Related: $0
  • Other: $0
Cate Hankins (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
David Cook (Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Elizabeth Bukusi (Secretary)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jeff O'Malley (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jesse Milan (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jintanat Ananworanich (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Kenly Sikwese (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Linda-Gail Bekker (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Marina Caskey (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sarah Schlesinger (Board Member (Until 12/2022))
  • Compensation: $0
  • Related: $0
  • Other: $0
Susie Mclean (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Vuyiseka Dubula (Board Member (Until 12/2022))
  • Compensation: $0
  • Related: $0
  • Other: $0
Yvonne Muthoni (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Erin Kiernon (Chief Operating Officer)
  • Compensation: $240,612
  • Related: $0
  • Other: $56,351
Abigail Smith (Chief Financial Officer)
  • Compensation: $205,567
  • Related: $0
  • Other: $57,951
Jessica Rodrigues (Director: Product Introduction)
  • Compensation: $158,028
  • Related: $0
  • Other: $18,473
Grant Deirdre (Director: Program Coordination)
  • Compensation: $158,631
  • Related: $0
  • Other: $24,116
Stacey Humphries (Director: Research Engagement)
  • Compensation: $178,707
  • Related: $0
  • Other: $56,085
Manju Chatani (Director: Partnerships & Capacity Strengthening)
  • Compensation: $187,879
  • Related: $0
  • Other: $43,194
Wanda Buckner (Director: Finance)
  • Compensation: $165,791
  • Related: $0
  • Other: $55,041


Official website here: www.avac.org

Where can I find the form 990 for Aids Vaccine Advocacy Coalition?

Aids Vaccine Advocacy Coalition's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.avac.org

Learn more at the official website: www.avac.org

Mission Statement of Aids Vaccine Advocacy Coalition

The Aids Vaccine Advocacy Coalition, or AVAC, is a dedicated organization working toward the ethical development and accessibility of effective HIV prevention options for those in need. The Coalition's primary commitment is to accelerate the process of creating and delivering these prevention methods as part of a comprehensive pathway to global health equity.

AVAC's mission is multifaceted, focusing on product introduction and access. Their Product Introduction Program aims to identify gaps and provide targeted tools and support to expand access to HIV/AIDS prevention. This program encompasses the successful scale-up and introduction of prevention in priority countries, the development of adaptable and scalable tools for other nations, the encouragement of marketable products in the HIV prevention and sexual and reproductive health research pipeline, and the creation of a flexible mechanism to help product developers, funders, and country programs address barriers to improved products and accelerated introduction.

AVAC collaborates with a network of funders, product developers, and governmental and non-governmental organizations, including the Bill and Melinda Gates Foundation, Children's Investment Fund Foundation, World Health Organization, Population Council, Viaris, Mann Global Health, Medicines360, USAID, Catalyst Global, HIV Prevention Trials Network, and Clinton Health Access Initiative, to implement these projects. AVAC's mission is crucial in the global fight against HIV/AIDS, working diligently to ensure that effective prevention options become accessible to everyone who needs them.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

The AIDS Vaccine Advocacy Coalition (AVAC) plays a pivotal role in enhancing the global response to HIV prevention. By advocating for the ethical development of effective prevention options, AVAC is instrumental in ensuring that these solutions are accessible to those who need them most. Their comprehensive approach focuses on identifying needs and gaps in HIV/AIDS prevention, facilitating the introduction of marketable products, and supporting their scale-up in priority countries.

AVAC’s initiatives are structured to create adaptable and scalable tools that can be utilized across various nations, directly addressing barriers to improved prevention options. This collaborative effort involves partnerships with notable organizations, including the Bill and Melinda Gates Foundation, WHO, and USAID, amplifying their impact in the field. Through these alliances, AVAC not only fosters innovation in HIV prevention and sexual and reproductive health but also contributes significantly to advancing global health equity.




This information is meant to be a general summary of Aids Vaccine Advocacy Coalition. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$14,790,975 (2022)
Expenses
$13,528,583 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $14,271
  • Gross Receipts: $14,790,975

Assets and Liabilities:

  • Total Assets: $7,187,054
  • Total Liabilities: $800,116
  • Net Assets: $6,386,938

Want to help this charity, for free? You can click here to learn more about Give Freely

Organization Details

Founding Year

1995

Principal Officer

Mitchell Warren

Main Address

ELLENOFF GROSSM 1345 6TH AVE FL11, NEW YORK, NY, 101050013

NTEE Category

Code: P20 - Human services

If you are a representative of Aids Vaccine Advocacy Coalition and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.